First Report of Schistosoma mekongi Infection with Brain Involvement

Houston, Stan; Kowalewska-Grochowska, Kinga; Naik, Sandeep; McKean, John; Johnson, E. S.; Warren, Ken
January 2004
Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, pe1
Academic Journal
We describe, to our knowledge, the first reported case of Schistosoma mekongi infection with brain involvement. S. mekongi is a distinct species most closely related to Schistosoma japonicum that is endemic in a defined area of the Mekong River in Laos and Cambodia and characteristically associated with hepatosplenic disease. The patient had an excellent response to praziquantel therapy but required repeated courses of corticosteroid therapy to suppress recrudescent neurological symptoms.


Related Articles

  • Treatment of Neurosarcoidosis. Safdieh, Joseph E. // Neurology Alert;Jul2007, Vol. 25 Issue 11, p85 

    NEUROLOGICAL INVOLVEMENT IS ENCOUNTERED IN approximately 5% of cases of systemic sarcoidosis. Both the central and peripheral nervous systems can be involved. The more common central nervous system manifestations include cranial neuropathies, chronic meningitis, myelopathy, and intraparenchymal...

  • Neurobehçet: a propósito de un caso. González, Germán Latorre; Gascón, Ana Belén Escribano; de Miguel, Carlos López de Silanes; Cobos, Rocío García; Peño, Luis Ignacio Casanova; Montero, Teresa Lapeña // Reumatologia Clinica;jul/ago2009, Vol. 5 Issue 4, p168 

    Behçet's disease is an inflammatory systemic disorder, with oral and genital ulcers, as well as ophthalmologic and cutaneous disturbances. 5% of the patients have neurological alterations. We present a case of neuroBehçet with a rare neurological involvement. A 28 years-old male patient...

  • Improved detection of microbubble signals using power M mode Doppler.  // Canadian Journal of Neurological Sciences;May2003 Supplement 2, Vol. 30, pS76 

    Presents an abstract of the study 'Improved Detection of Microbubble Signals Using Power M Mode Doppler' submitted to the 38th meeting of the Canadian Congress of Neurological Sciences.

  • Non-infectious orbital vasculitides. Perumal, B; Black, E H; Levin, F; Servat, J J // Eye;May2012, Vol. 26 Issue 5, p630 

    Non-infectious vasculitides comprise a large number of diseases. Many of these diseases can cause inflammation within the orbit and a clinical presentation, which mimics numerous other processes. Orbital disease can often be the initial presentation of a systemic process and early diagnosis can...

  • Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Saavedra, Michael C.; Sur, Sanjiv // Clinical & Molecular Allergy;2011, Vol. 9 Issue 1, p1 

    Chronic idiopathic urticaria is a condition that is often controllable with antihistamine therapy. However, some patients have disease burden that is difficult to manage, non-responsive to antihistamines and often requires immunosuppressive medications such as corticosteroids or cyclosporine. We...

  • Clinical and radiological features of Takayasu’s arteritis patients in Jordan. Mustafa, Khader N.; Hadidy, Azmy; Sweiss, Nadera J. // Rheumatology International;Sep2010, Vol. 30 Issue 11, p1449 

    The prevalence of Takayasu’s arteritis (TA) varies greatly among world populations, and little is known about this disease in Eastern Mediterranean Arab populations. We conducted a retrospective chart review of patients diagnosed with TA from 1996 to 2008 at a single large referral center...

  • Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates. Ringe, Johann D.; Farahmand, Parvis // Clinical Rheumatology;Apr2007, Vol. 26 Issue 4, p474 

    Corticosteroids are widely used as anti-inflammatory and immunosuppressive agents to treat a variety of chronic conditions. Long-term (>1 year) corticosteroid use can lead to bone loss, and therefore, osteopenia or osteoporosis. Corticosteroid-induced osteoporosis (CIO) leads to increased bone...

  • Corticosteroids/immunosuppressants.  // Reactions Weekly;9/29/2007, Issue 1171, p11 

    The article presents eight cases of the development of cancer during treatment with a ciclosporin-based immunosuppressive regimen with corticosteroids. The patients were placed under the regimen after they had kidney transplantation. Based on the article, the patients who underwent major surgery...

  • A comparison of resource utilization and costs in patients with pemphigus and pemphigoid 6 months before and 6 months after rituximab treatment. Heelan, K.; Shear, N.; Knowles, S.; Hassan, S.; Mittmann, N. // Journal of Population Therapeutics & Clinical Pharmacology;2014, Vol. 21 Issue 1, pe141 

    Introduction: Pemphigus and pemphigoid are a rare group of potentially fatal diseases, causing blistering on mucosal and epidermal surfaces. Long-term systemic treatment with systemic corticosteroids and immunosuppressive agents including IVIg are usually required. Rituximab (RTX) is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics